Verteporfin photodynamic therapy for neovascular age-related ...

124 Appendix 113. Organisation13.1 Steering Committee and other key personnelThe Steering Committee consists of the individuals listed in Table 2.Table 2: Members of the Steering CommitteeChairDeputy Chair, and representative of theRCOphth Scientific CommitteeRetina specialistsEditor, Cochrane Eyes and VisionCollaborative Review GroupPublic Health ConsultantIndependent Scientific AdvisorData Management Centre representativeMr N AstburyMr D WongProfessor A Bird,Professor U Chakravarthy,Mr S Harding,Mr B Dhillon,Mr Y YangMr R WormaldDr D AustinProfessor A FletcherDr B ReevesNCCHTA representative Professor K Woods (until 31/10/03),Dr P Davidson (from 01/11/03)Consumer representativeMr T BremridgeDepartment of Health representative Mr D BusbyNovartis representative Mr N Gwatkin (until 29/02/04),Ms J Potts (from 01/03/04)Representative for Local Specialist Mr Peter GrahamCommissioners13.2 Data safety and monitoringThe Steering Committee has taken responsibility for data and safety monitoring. TheData Management Centre has responsibility for regular submission of a core set ofsummary descriptive data for review by the Committee. The details of thesesummary statistics have not yet been finalised, but will include all reports of adverseevents, recruitment rates overall and by DP, and details of treatments given by CNVcategory.